Cupping in Osteoarthritis of the Knee
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Device: Pulsatile cupping
- Registration Number
- NCT01057043
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
The purpose of this exploratory randomised trial is to study the effect of pulsatile cupping in osteoarthritis of the knee compared to waiting list control.
- Detailed Description
Cupping is a traditional therapy in many cultures of the world and is used to treat osteoarthritis of the knee. In this randomised trial we want to study the effect of pulsatile cupping in osteoarthritis of the knee compared to waiting list control. Pulsatile cupping is administered by a special cupping machine (HeVaTec) with silicone cupping glasses to the knee joint. Pulsatile pressure is generated by a pump that generates vacuum.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Osteoarthritis of the knee according ACR-criteria
- X-ray classification minimum Kellgren-Lawrence criteria grade 2
- Pain Intensity > 40 mm VAS
- Only therapy with NSAIDin the last 4 weeks
- Informed consent
- Use of anticoagulants (Phenprocoumon, Heparin)
- Coagulopathy
- Cupping in the last 12 months
- Intraarticular injection of corticosteroids or NSAID into the knee joint in the last 4 months
- Use of systemic corticosteroids in the last 4 weeks
- Physical therapy, leeches or acupuncture in the last 4 months
- Other CAM therapies for the osteoarthritis in the last 4 weeks
- Arthroscopy of the knee joint in the last 12 months
- Paracetamol allergy or intolerance
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Cupping Pulsatile cupping In case of acute pain patients may take paracetamol as rescue medication, maximum dosage 2 gram per day.
- Primary Outcome Measures
Name Time Method Western Ontario and McMaster Universities Osteoarthritis (WOMAC) - Score 4 weeks
- Secondary Outcome Measures
Name Time Method Use of rescue medication (paracetamol) weeks 1-4 Western Ontario and McMaster Universities Osteoarthritis (WOMAC) - Scores 12 weeks Pain Intensity (Visual Analogue Scale; no pain=0; maximum pain=100 mm) week 4 and 12 Quality of Life (SF 36) 4 and 12 weeks Adverse events and serious adverse events continously Global assessment of efficacy by patients week 4 and 12
Trial Locations
- Locations (1)
Institiute for Social Medicine, Epidemiology and Health Economy, Charité University Berlin
🇩🇪Berlin, Germany